Cerebrospinal fluid glutamate levels in chronic migraine.

Hospital Israelita Albert Einstein, Instituto de Ensino e Pesquisa, São Paulo, Brazil.
Cephalalgia (Impact Factor: 4.12). 10/2004; 24(9):735-9. DOI: 10.1111/j.1468-2982.2004.00750.x
Source: PubMed

ABSTRACT Both preclinical and clinical data link glutamate to the migraine pathophisiology. Altered plasma, platelets and cerebrospinal (CSF) glutamate levels have been reported in migraine patients. Chronic migraine is comorbid with several conditions. It has been recently shown chronic migraine comorbidity with fibromyalgia. The objective of this study was to study cerebrospinal fluid glutamate levels in chronic migraine patients with and without fibromyalgia. We studied 20 chronic migraine patients, with and without fibromyalgia, compared to age-sex matched controls. CSF glutamate levels were measured by HPLC. CSF glutamate demonstrated significantly higher levels in patients with fibromyalgia compared to those without fibromyalgia. Patients overall had higher CSF glutamate levels than controls. Mean pain score correlated with glutamate levels in chronic migraine patients. Tender points, the hallmark of fibromyalgia, can be considered as pressure allodynia, and is probably mediated by central sensitization, with increase in CSF glutamate levels. We postulate chronic migraine patients with fibromyalgia, in addition to have more disabling headaches, suffer from a more severe central sensitization process. This subtype of patients may respond to medications modulating glutamate receptors. Headache intensity correlate with glutamate levels in chronic migraine patients.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: to carry out a literature review of the evidence concerning the association of fibromyalgia and headache. METHOD: a search of databases was conducted using the keywords: fibromyalgia, headache, migraine, and tension-type headache. Abstracts which appeared to fulfill the initial selection criteria were selected and the original articles were retrieved. RESULT: seven studies met all inclusion criteria. Between 35% and 88.4% fibromyalgia patients were diagnosed as suffering of headache; 17.4% to 40% patients with headache were diagnosed as suffering of fibromyalgia. CONCLUSION: it is not clear if headache is more prevalent in fibromyalgia patients. However, fibromyalgia is more prevalent in primary headache patients, especially migraine.
    Revista Brasileira de Reumatologia 04/2007; 47(2):114-120. · 0.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The primary brain dysfunctions leading to the onset of a migraine attack remain largely unknown. Other important open questions concern the mechanisms of initiation, continuation, and termination of migraine pain, and the changes in brain function underlying migraine transformation. Brief trains of high-frequency repetitive transcranial magnetic stimulation (rTMS), when applied to the primary motor cortex at suprathreshold intensity (⩾ 120% of resting motor threshold, RMT), elicit in healthy subjects a progressive, glutamate-dependent facilitation of the Motor Evoked Potentials (MEP). Conversely, in conditions of increased cortical excitability, the rTMS trains induce inhibitory MEP responses likely mediated by cortical homeostatic mechanisms. We enrolled 66 migraine without aura (MwoA) patients, 48 migraine with aura (MwA) patients, 14 patients affected by chronic migraine (CM), and 20 healthy controls. We assessed motor cortical response to 5-Hz rTMS trains of 10 stimuli given at 120% RMT. Patients with episodic migraine (EM) were studied in different phases of the migraine cycle, i.e. interictal, preictal, ictal and postictal state. Results showed a facilitatory MEP response during the trains in patients evaluated in the preictal phase, whilst inhibitory responses were observed during and after a migraine attack, as well as in CM patients. In the interictal phase, different responses were observed depending on attack frequency: facilitation in patients with low and inhibition with those with high attack recurrence. Our findings suggest that changes in cortical excitability and fluctuations in the threshold for inhibitory metaplasticity underlie the migraine attack recurrence, and could be involved in the process of migraine transformation.
    Pain 03/2014; 155(6). DOI:10.1016/j.pain.2014.02.024 · 5.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The analgesic action of botulinum neurotoxin type A (BoNTA) has been linked to the blockade of peripheral release of neuropeptides and neurotransmitters in animal models; however, there is no direct evidence of this in humans.

Full-text (2 Sources)

Available from
May 16, 2014